These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9812205)
41. APOE4 testing for Alzheimer's disease. Karlawish JH; Sachs GA J Am Geriatr Soc; 1997 Sep; 45(9):1153-4. PubMed ID: 9288030 [No Abstract] [Full Text] [Related]
42. Dog from hell chases Alzheimer's. Brower V Nat Biotechnol; 1997 Apr; 15(4):311. PubMed ID: 9094117 [No Abstract] [Full Text] [Related]
43. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
44. Re: Genetic effect of alpha 1-antichymotrypsin on the risk of Alzheimer disease. Kamboh MI; Aston CE; Ferrell RE; Dekosky ST Genomics; 1997 Mar; 40(2):382-5. PubMed ID: 9119413 [No Abstract] [Full Text] [Related]
48. The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease. van Gool WA Ann N Y Acad Sci; 1996 Dec; 802():79-91. PubMed ID: 8993487 [No Abstract] [Full Text] [Related]
49. [Current genetic linkages of Alzheimer's disease]. Haltia M Duodecim; 1995; 111(5):389-92. PubMed ID: 8674440 [No Abstract] [Full Text] [Related]
50. Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease. Lucotte G; Turpin JC; Landais P Ann Neurol; 1994 Oct; 36(4):681-2. PubMed ID: 7944308 [No Abstract] [Full Text] [Related]
51. The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease. Schenk D; Lieberburg I; Motter R; Seubert P Ann N Y Acad Sci; 1996 Dec; 802():92-100. PubMed ID: 8993488 [No Abstract] [Full Text] [Related]
56. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies. Huang Y Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223 [TBL] [Abstract][Full Text] [Related]
57. Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease. Camicioli R; Kryscio R Neurology; 2005 Dec; 65(12):1855-6. PubMed ID: 16380605 [No Abstract] [Full Text] [Related]
58. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636 [No Abstract] [Full Text] [Related]
59. Apolipoprotein E in neurology. Roses AD Curr Opin Neurol; 1996 Aug; 9(4):265-70. PubMed ID: 8858183 [TBL] [Abstract][Full Text] [Related]
60. Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease. Kölsch H; Ptok U; Bagli M; Papassotiropoulos A; Schmitz S; Barkow K; Kockler M; Rao ML; Maier W; Heun R Ann Neurol; 2001 Jun; 49(6):818-9. PubMed ID: 11409442 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]